Figure 2. Overall attitudes toward cancer immunotherapy. Participants were asked “Please indicate your overall attitude to cancer immunotherapeutics/therapeutic cancer vaccines where 1 means not at all favorable and 7 means extremely favorable.” Responses were classified as “Positive” (rating of 6 or 7), “Neutral” (4 or 5), or “Negative” (1–3).